Japan's First Surgical-Specialized Generative AI 'Surgical VLM' Developed to Act as a 'Brain' in the Operating Room
Direava has developed Japan's first surgical-specialized generative AI, 'Surgical VLM', which understands and discusses surgical situations in real-time. Clinical validation at Keio University Hospital demonstrated high anatomical accuracy and clinical utility. The company aims to commercialize the technology in 2026 to enhance surgical education and patient safety.
📋 Article Processing Timeline
- 📰 Published: March 28, 2026 at 16:04
- 🔍 Collected: March 28, 2026 at 21:59 (5h 54m after Published)
- 🤖 AI Analyzed: April 15, 2026 at 06:41 (416h 41m after Collected)
Under the GENIAC project, Direava Co., Ltd. has developed 'Surgical VLM,' a generative AI model specifically for surgery that can understand and engage in dialogues about operative procedures in real-time. Unlike previous tools focusing solely on anatomical identification, this AI functions like a surgeon's 'brain' to suggest procedural steps. Validated on February 20, 2026, at Keio University Hospital during gastric cancer surgeries, the AI achieved high scores for anatomical accuracy (84.7%) and clinical utility (82.9%). Direava plans to commercialize the technology within 2026, aiming to improve surgical training and quality of care.
FAQ
What does this AI do?
It understands surgical imagery in real-time and engages in dialogue with surgeons regarding next steps and potential risks.
When will it be commercialized?
The company is preparing for commercialization within 2026.